Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

American Oriental Bioengineering Gets NYSE Non-compliance Notice

American Oriental Bioengineering, Inc. (AOB: Quote) on Friday said the New York Stock Exchange has notified the company that it is not in compliance with NYSE rules due to the company's failure to timely file its Annual Report on Form 10-K with the Securities and Exchange Commission.

The company had said earlier that the annual audit of its financial statements for 2011 showed some inconsistencies and the audit committee has commenced an independent investigation into those matters.

Under NYSE rules, when a company does not comply with annual report filing requirements, the exchange allows a company an additional six months to file its annual report in order to regain compliance. In the case of the company, the annual report would be due on or before October 29.

Click here to receive FREE breaking news email alerts for American Oriental Bioengineering Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After seeing initial strength on the heels of upbeat economic data, stocks have fluctuated over the course of early trading on Wednesday. The major averages have pulled back off their highs for the young session, with the Dow sliding into negative territory. After reporting a notable contraction in U.S. economic activity in the first quarter, the Commerce Department released a report on Wednesday showing that gross domestic product rebounded by more than anticipated in the second quarter. Employment in the U.S. private sector continued to see notable growth in the month of July, according to a report released by payroll processor ADP on Wednesday, although the pace of job growth came in below economist estimates.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.